Christopher Heery
Chief Tech/Sci/R&D Officer bij ARCELLX, INC.
Vermogen: 621 638 $ op 31-03-2024
Profiel
Christopher R.
Heery is currently the Chief Medical Officer at Arcellx, Inc. Prior to this, he was the Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
He also held the position of Chief Medical Officer at Bavarian Nordic A and was the Head-Clinical Trials at the National Cancer Institute.
Heery received his undergraduate degree from Duke University and his doctorate from Brody School of Medicine in 2006.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARCELLX, INC.
0.02% | 26-03-2024 | 8 938 ( 0.02% ) | 621 638 $ | 31-03-2024 |
Actieve functies van Christopher Heery
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 01-04-2021 |
Eerdere bekende functies van Christopher Heery
| Bedrijven | Functie | Einde |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 23-04-2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | - |
Opleiding van Christopher Heery
| Duke University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| ARCELLX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
